bleximenib
N-ethyl-5-fluoro-2-[[5-[2-[(3R)-6-[2-methoxyethyl(methyl)amino]-2-methylhexan-3-yl]-2,7-diazaspiro[3.4]octan-7-yl]-1,2,4-triazin-6-yl]oxy]-N-propan-2-ylbenzamide
Molecular Identity
bleximenib
N-ethyl-5-fluoro-2-[[5-[2-[(3R)-6-[2-methoxyethyl(methyl)amino]-2-methylhexan-3-yl]-2,7-diazaspiro[3.4]octan-7-yl]-1,2,4-triazin-6-yl]oxy]-N-propan-2-ylbenzamide
PubChem CID: 156498110
2D Structure
Properties
C32H50FN7O3
Molecular Formula
599.80
Molecular Weight
g/mol
599.3959
Exact Mass
Da
4.3
XLogP
Drug-like (Lipinski: < 5)
87.2
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
10
H-Bond Acceptors
861
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
bleximenib2654081-35-1DCN5WEN78TN-ethyl-5-fluoro-2-[[5-[2-[(3R)-6-[2-methoxyethyl(methyl)amino]-2-methylhexan-3-yl]-2,7-diazaspiro[3.4]octan-7-yl]-1,2,4-triazin-6-yl]oxy]-N-propan-2-ylbenzamideN-ethyl-5-fluoro-2-((5-(2-((3R)-6-(2-methoxyethyl(methyl)amino)-2-methylhexan-3-yl)-2,7-diazaspiro(3.4)octan-7-yl)-1,2,4-triazin-6-yl)oxy)-N-propan-2-ylbenzamideRefChem:1080046Menin-MLL inhibitor 24N-ethyl-5-fluoro-2-{[5-(2-{(3R)-6-[(2-methoxyethyl)(methyl)amino]-2-methylhexan-3-yl}-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl]oxy}-N-(propan-2-yl)benzamidebleximenib [INN]CHEMBL5314509SCHEMBL23529638SCHEMBL30128634EX-A8746AGTPL12866BDBM689589
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to bleximenib
Loading drug network...